Yilan Huang Selected Research

Timolol (Blocadren)

1/2019

Efficacy and Safety of Brinzolamide as Add-On to Prostaglandin Analogues or β-Blocker for Glaucoma and Ocular Hypertension: A Systematic Review and Meta-Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yilan Huang Research Topics

Disease

4	Neoplasms (Cancer) 01/2024 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 04/2023
3	Obesity 01/2023 - 01/2022
3	Insulin Resistance 05/2022 - 01/2022
2	Weight Loss (Weight Reduction) 01/2023 - 06/2016
2	Inflammation (Inflammations) 05/2022 - 01/2022
1	Heart Diseases (Heart Disease) 04/2024
1	Pulmonary Arterial Hypertension 04/2024
1	Pulmonary Hypertension 04/2024
1	Kidney Diseases (Kidney Disease) 05/2023
1	Hyponatremia 05/2023
1	Neoplasm Metastasis (Metastasis) 04/2023
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Carcinogenesis 01/2023
1	Body Weight (Weight, Body) 01/2022
1	Hyperglycemia 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022
1	Glucose Intolerance 01/2022
1	Cognitive Dysfunction 01/2022
1	Dysbiosis 01/2022
1	Atherosclerosis 11/2021
1	Diabetes Complications 04/2021
1	Infections 01/2020
1	Pruritus (Itching) 01/2019
1	Ocular Hypertension (Glaucoma, Suspect) 01/2019
1	Eye Pain 01/2019
1	Hyperemia 01/2019
1	Glaucoma 01/2019
1	Foreign Bodies (Foreign Body) 01/2019
1	Conjunctivitis 01/2019
1	Type 2 Diabetes Mellitus (MODY) 06/2016
1	Major Depressive Disorder (Major Depressive Disorders) 01/2016

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 06/2016
2	Sodium-Glucose Transporter 2 InhibitorsIBA 04/2024 - 05/2023
2	Polysaccharides (Glycans)IBA 04/2023 - 01/2022
2	Butyrates (Butyrate)IBA 01/2023 - 01/2022
2	CholesterolIBA 01/2022 - 11/2021
1	LipidsIBA 01/2024
1	fasudil (AT 877)IBA 01/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024
1	Tyrosine Kinase InhibitorsIBA 01/2024
1	lenvatinibIBA 01/2024
1	SodiumIBA 05/2023
1	ElectrolytesIBA 05/2023
1	SugarsIBA 04/2023
1	NucleotidesIBA 04/2023
1	IronIBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 05/2022
1	Insulin (Novolin)FDA Link 05/2022
1	biapenem (L 627)IBA 01/2022
1	Meropenem (Merrem)FDA LinkGeneric 01/2022
1	Dehydroepiandrosterone (DHEA)IBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	PlatinumIBA 01/2022
1	Enoxacin (AT 2266)FDA Link 01/2022
1	tau Proteins (tau Protein)IBA 01/2022
1	Butyric Acid (Butanoic Acid)IBA 01/2022
1	Hypoxia-Inducible Factor 1IBA 04/2021
1	VaccinesIBA 01/2020
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 01/2019
1	Carbonic Anhydrase InhibitorsIBA 01/2019
1	dorzolamide (Trusopt)FDA LinkGeneric 01/2019
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2019
1	Timolol (Blocadren)FDA LinkGeneric 01/2019
1	brinzolamide (Azopt)FDA Link 01/2019
1	DisulfidesIBA 01/2018
1	RheniumIBA 01/2018
1	ResveratrolIBA 01/2018
1	AlbuminsIBA 01/2018
1	empagliflozinIBA 06/2016
1	Metformin (Glucophage)FDA LinkGeneric 06/2016
1	LevomilnacipranIBA 01/2016

Therapy/Procedure

3	Therapeutics 04/2024 - 01/2019
1	Oral Administration 05/2023
1	Length of Stay 05/2023
1	Immunotherapy 01/2023